Stay updated with breaking news from Carrier Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Genetic Testing Market is Segmented by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic...
Genetic Testing Market to Grow at 9.6?GR during 2021-2027, Impelled by Increasing Burden of Cancers Worldwide
Genetic Testing Market to Grow at 9.6?GR during 2021-2027, Impelled by Increasing Burden of Cancers Worldwide
According to latest report “Genetic Testing Market by Test Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Nutrigenomic Testing), Application (Cancer, Genetic Disease, Cardiovascular Disease), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027”, by Global Market Insights Inc., the market valuation of genetic testing will cross $31.8 billion by 2027. Availability of different genetic tests across the globe for early and accurate disease diagnosis will enhance the market growth during the forecast ...
Global Genetic Testing Market Outlook to 2022 Featuring Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Thermo Fisher Scientific, Hologic, Cepheid, Agilent Technologies, and QIAGEN News provided by Share this article Share this article ResearchAndMarkets.com's offering. "Global Genetic Testing Market Outlook 2022" provides a detailed analysis of the genetic testing market. The report also provides insight regarding the current and future perspectives of the market. This report covers the major trends and drivers, and their impact on the market. The report also discusses some of the...